{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T11:51:43Z","timestamp":1792929103891,"version":"4.5.0"},"reference-count":236,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2007,5,14]],"date-time":"2007-05-14T00:00:00Z","timestamp":1179100800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Addiction Biology"],"published-print":{"date-parts":[[2007,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Despite huge advances in the neuroscience of substance abuse and dependence in the past 20\u2003years, no approved pharmacological treatment exists for cocaine abuse. The available drugs for the treatment of cocaine abuse are poorly effective, hence the need for new compounds to be screened and tested for efficacy: targeting symptoms might improve the effectiveness of the treatment of cocaine abuse and dependence. On the basis of the known neurochemistry of cocaine, some target compounds have been studied: among others, BP\u2010897, a D3 partial agonist; vanoxerine, a highly selective inhibitor of dopamine uptake; aripiprazole, a partial mixed\u2010action agonist approved for the treatment of schizophrenia. Recently modafinil, approved for the treatment of narcolepsy, proved effective in favouring cocaine abstinence in cocaine\u2010abusing people. Some placebo\u2010controlled studies also reported the effectiveness of topiramate, a licensed antiepileptic drug, and of tiagabine, a gamma\u2010aminobutyric acid (GABA) re\u2010uptake inhibitor also approved as an anticonvulsant; both compounds increased cocaine abstinence with no serious adverse events. Promising results came from two more compounds acting on the GABA circuits, baclofen and valproic acid. Finally disulfiram, prescribed with active psychosocial therapy, was found to favour higher retention rates and longer abstinence periods from both alcohol and cocaine in polydrug\u2010abusing patients. An alternative approach rests on the use of vaccines, to date in the experimental stage still. Psychosocial treatments are a useful companion in the pharmacotherapy of cocaine abuse, with group therapy and contingency management therapies improving motivation and social functioning, particularly in patients abusing alcohol as well.<\/jats:p>","DOI":"10.1111\/j.1369-1600.2007.00061.x","type":"journal-article","created":{"date-parts":[[2007,5,14]],"date-time":"2007-05-14T13:45:24Z","timestamp":1179150324000},"page":"133-151","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["REVIEW: New developments in the pharmacotherapy of cocaine abuse"],"prefix":"10.1111","volume":"12","author":[{"given":"Antonio","family":"Preti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,5,14]]},"reference":[{"key":"e_1_2_17_2_1","unstructured":"Ait\u2010DaoudN JohnsonBA(2004) Open\u2010label trial of topiramate for treating cocaine dependence. Presented at the College on Problems of Drug Dependence annual meeting June 13 San Juan."},{"key":"e_1_2_17_3_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v61n1205"},{"key":"e_1_2_17_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(89)90363-4"},{"key":"e_1_2_17_5_1","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1300.023"},{"key":"e_1_2_17_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(96)00164-9"},{"key":"e_1_2_17_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(96)01233-1"},{"key":"e_1_2_17_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(00)00100-7"},{"key":"e_1_2_17_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.4.426"},{"key":"e_1_2_17_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000169419.38899.5b"},{"key":"e_1_2_17_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2005.00983.x"},{"key":"e_1_2_17_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2005.01106.x"},{"key":"e_1_2_17_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(99)00927-9"},{"key":"e_1_2_17_14_1","first-page":"497","article-title":"Effects of calcium channel antagonists on the reinforcing properties of morphine, ethanol and cocaine as measured by place conditioning","volume":"47","author":"Biala G","year":"1996","journal-title":"J Physiol Pharmacol"},{"key":"e_1_2_17_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2005.07.009"},{"key":"e_1_2_17_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001504-200005000-00016"},{"key":"e_1_2_17_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/37.5.478"},{"key":"e_1_2_17_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(99)00094-5"},{"key":"e_1_2_17_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-001-0952-7"},{"key":"e_1_2_17_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2003.09.032"},{"key":"e_1_2_17_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/syn.10278"},{"key":"e_1_2_17_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/syn.20097"},{"key":"e_1_2_17_23_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n0613"},{"key":"e_1_2_17_24_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n0213"},{"key":"e_1_2_17_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2006.02.001"},{"key":"e_1_2_17_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijir.3900722"},{"key":"e_1_2_17_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1521-0391.1998.tb00329.x"},{"key":"e_1_2_17_28_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.8099761"},{"key":"e_1_2_17_29_1","first-page":"209","article-title":"Effects of dopamine D\u20101 and D\u20102 antagonists on cocaine self\u2010administration under different schedules of reinforcement in the rat","volume":"270","author":"Caine SB","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_17_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2005.04.017"},{"key":"e_1_2_17_31_1","doi-asserted-by":"publisher","DOI":"10.1037\/1064-1297.6.3.274"},{"key":"e_1_2_17_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2003.11.015"},{"key":"e_1_2_17_33_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.98.4.1988"},{"key":"e_1_2_17_34_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm9706729"},{"key":"e_1_2_17_35_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.61.3.264"},{"key":"e_1_2_17_36_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1998.9357137.x"},{"key":"e_1_2_17_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300169"},{"key":"e_1_2_17_38_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.physiol.67.040403.120816"},{"key":"e_1_2_17_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/nn0901-873"},{"key":"e_1_2_17_40_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.4.2.243"},{"key":"e_1_2_17_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2005.00984.x"},{"key":"e_1_2_17_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2005.00985.x"},{"key":"e_1_2_17_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008877-199811000-00014"},{"key":"e_1_2_17_44_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.2.210"},{"key":"e_1_2_17_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(01)00163-6"},{"key":"e_1_2_17_46_1","doi-asserted-by":"publisher","DOI":"10.3109\/00952999509002701"},{"key":"e_1_2_17_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-004-0018-8"},{"key":"e_1_2_17_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300600"},{"key":"e_1_2_17_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(02)00335-6"},{"key":"e_1_2_17_50_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001504-200205000-00006"},{"key":"e_1_2_17_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/nn1105-1431"},{"key":"e_1_2_17_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(02)00019-4"},{"key":"e_1_2_17_53_1","first-page":"542","article-title":"Ondansetron given in the acute withdrawal from a repeated cocaine sensitization dosing regimen reverses the expression of sensitization and inhibits self\u2010administration","volume":"27","author":"Davidson C","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"e_1_2_17_54_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200002001-00001"},{"key":"e_1_2_17_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300088"},{"key":"e_1_2_17_56_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.18-14-05529.1998"},{"key":"e_1_2_17_57_1","article-title":"Methadone maintenance at different dosages for opioid dependence","volume":"3","author":"Faggiano F","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_17_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresrev.2006.05.003"},{"key":"e_1_2_17_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2006.04.010"},{"key":"e_1_2_17_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(98)00085-2"},{"key":"e_1_2_17_61_1","first-page":"685","article-title":"The serotonergic system and its role in cocaine addiction","volume":"57","author":"Filip M","year":"2005","journal-title":"Pharmacol Rep"},{"key":"e_1_2_17_62_1","doi-asserted-by":"publisher","DOI":"10.1037\/1064-1297.11.2.123"},{"key":"e_1_2_17_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(97)00121-X"},{"key":"e_1_2_17_64_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1096-1129"},{"key":"e_1_2_17_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2005.05.011"},{"key":"e_1_2_17_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3458.2003.tb00246.x"},{"key":"e_1_2_17_67_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1989.01810040028005"},{"key":"e_1_2_17_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.12.067"},{"key":"e_1_2_17_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(99)00310-8"},{"key":"e_1_2_17_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(00)00267-3"},{"key":"e_1_2_17_71_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3458.2001.tb00201.x"},{"key":"e_1_2_17_72_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1024295422944"},{"key":"e_1_2_17_73_1","doi-asserted-by":"publisher","DOI":"10.1037\/1064-1297.3.3.219"},{"key":"e_1_2_17_74_1","doi-asserted-by":"publisher","DOI":"10.1037\/1064-1297.3.3.232"},{"key":"e_1_2_17_75_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199346030-00007"},{"key":"e_1_2_17_76_1","first-page":"205","volume-title":"Substance Abuse. A Comprehensive Textbook","author":"Gold MK","year":"1992"},{"key":"e_1_2_17_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2006.07.003"},{"key":"e_1_2_17_78_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2003.00544.x"},{"key":"e_1_2_17_79_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200464140-00004"},{"key":"e_1_2_17_80_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200110000-00010"},{"key":"e_1_2_17_81_1","first-page":"21","article-title":"Schizophrenia and comorbid substance use disorder: effects of antipsychotics","volume":"66","author":"Green AI","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_17_82_1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/hup.252","article-title":"A pilot open clinical study of depakote in the treatment of cocaine abuse","volume":"3","author":"Halikas JA","year":"2001","journal-title":"Hum Psychopharmacol"},{"key":"e_1_2_17_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(97)90155-7"},{"key":"e_1_2_17_84_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050925"},{"key":"e_1_2_17_85_1","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.3.1.11"},{"key":"e_1_2_17_86_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.265.6.760"},{"key":"e_1_2_17_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2003.10.015"},{"key":"e_1_2_17_88_1","doi-asserted-by":"publisher","DOI":"10.1037\/0893-164X.11.4.261"},{"key":"e_1_2_17_89_1","doi-asserted-by":"publisher","DOI":"10.1038\/35094560"},{"key":"e_1_2_17_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(99)00446-X"},{"key":"e_1_2_17_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-0186(00)00013-9"},{"key":"e_1_2_17_92_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200519100-00005"},{"key":"e_1_2_17_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2006.02.011"},{"key":"e_1_2_17_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjhyper.2005.01.020"},{"key":"e_1_2_17_95_1","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1300.009"},{"key":"e_1_2_17_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2006.04.002"},{"key":"e_1_2_17_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2004.03.008"},{"key":"e_1_2_17_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(03)00009-7"},{"key":"e_1_2_17_99_1","doi-asserted-by":"publisher","DOI":"10.1080\/10550490490265389"},{"key":"e_1_2_17_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0740-5472(99)00076-8"},{"key":"e_1_2_17_101_1","doi-asserted-by":"publisher","DOI":"10.1080\/09595230412331324518"},{"key":"e_1_2_17_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pscychresns.2003.12.001"},{"key":"e_1_2_17_103_1","doi-asserted-by":"publisher","DOI":"10.2174\/1568007023339049"},{"key":"e_1_2_17_104_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.142.11.1259"},{"key":"e_1_2_17_105_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1948035"},{"key":"e_1_2_17_106_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2005.06.009"},{"key":"e_1_2_17_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00425-X"},{"key":"e_1_2_17_108_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.164.3.277"},{"key":"e_1_2_17_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(96)00440-6"},{"key":"e_1_2_17_110_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd897"},{"key":"e_1_2_17_111_1","doi-asserted-by":"publisher","DOI":"10.1038\/nn1583"},{"key":"e_1_2_17_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/0166-2236(91)90141-G"},{"key":"e_1_2_17_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(92)90363-K"},{"key":"e_1_2_17_114_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(94)90310-7"},{"key":"e_1_2_17_115_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.104.077974"},{"key":"e_1_2_17_116_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-003-1391-4"},{"key":"e_1_2_17_117_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2003.00236.x"},{"key":"e_1_2_17_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(02)00067-4"},{"key":"e_1_2_17_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(98)00049-0"},{"key":"e_1_2_17_120_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199112000-00008"},{"key":"e_1_2_17_121_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2004.04.010"},{"key":"e_1_2_17_122_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300803"},{"key":"e_1_2_17_123_1","first-page":"CD002950","article-title":"Antidepressants for cocaine dependence","volume":"2","author":"De Lima MS","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_17_124_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2002.00209.x"},{"key":"e_1_2_17_125_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.105.084913"},{"key":"e_1_2_17_126_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(98)00050-7"},{"key":"e_1_2_17_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2005.03.026"},{"key":"e_1_2_17_128_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2004.12.006"},{"key":"e_1_2_17_129_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.1997.10400189"},{"key":"e_1_2_17_130_1","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(95)01198-6"},{"key":"e_1_2_17_131_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2005.04.032"},{"key":"e_1_2_17_132_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.149.3.371"},{"key":"e_1_2_17_133_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.22.1795"},{"key":"e_1_2_17_134_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2000.tb05213.x"},{"key":"e_1_2_17_135_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm960305h"},{"key":"e_1_2_17_136_1","doi-asserted-by":"publisher","DOI":"10.1080\/13556219872236"},{"key":"e_1_2_17_137_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002207.pub2"},{"key":"e_1_2_17_138_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1996.tb06038.x"},{"key":"e_1_2_17_139_1","doi-asserted-by":"publisher","DOI":"10.1016\/0893-133X(95)00274-H"},{"key":"e_1_2_17_140_1","doi-asserted-by":"publisher","DOI":"10.1300\/J069v20n03_08"},{"key":"e_1_2_17_141_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0740-5472(01)00202-1"},{"key":"e_1_2_17_142_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2003.09.004"},{"key":"e_1_2_17_143_1","first-page":"89","article-title":"The use of divalproex in the treatment of affective disorders","volume":"37","author":"Myrick H","year":"2003","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_17_144_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2001.10400575"},{"key":"e_1_2_17_145_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130100724"},{"key":"e_1_2_17_146_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2004.03.004"},{"key":"e_1_2_17_147_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2005.06.003"},{"key":"e_1_2_17_148_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.15.1887"},{"key":"e_1_2_17_149_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.8.1423"},{"key":"e_1_2_17_150_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300681"},{"key":"e_1_2_17_151_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(93)90500-F"},{"key":"e_1_2_17_152_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1369-1600.2006.00036.x"},{"key":"e_1_2_17_153_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0507332102"},{"key":"e_1_2_17_154_1","first-page":"1182","article-title":"Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine","volume":"274","author":"Parsons LH","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_17_155_1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1360-0443.2000.9522198.x","article-title":"Disulfiram treatment for cocaine dependence in methadone\u2010maintained opioid addicts","volume":"95","author":"Patrakis IL","year":"2000","journal-title":"Addiction"},{"key":"e_1_2_17_156_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2005.08.011"},{"key":"e_1_2_17_157_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M101287200"},{"key":"e_1_2_17_158_1","unstructured":"PillaM HutchesonDM Adib\u2010SamilP PottonE EverittBJ(2001)Seeking responses for cocaine heroin and natural reinforcers are differentially modulated by dopamine D3 receptors.Soc Neurosci Abstr647.16 Vol 27."},{"key":"e_1_2_17_159_1","doi-asserted-by":"publisher","DOI":"10.1038\/22560"},{"key":"e_1_2_17_160_1","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0022-3565(24)29288-0","article-title":"Discriminative stimulus effects of intravenous heroin and its mechanisms in rhesus monkey: opioid and dopaminergic mechanisms","volume":"299","author":"Platt DM","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_17_161_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-002-1137-8"},{"key":"e_1_2_17_162_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.2.219"},{"key":"e_1_2_17_163_1","first-page":"235","article-title":"100\u2003years of ibogaine: neurochemical and pharmacological actions of a putative anti\u2010addictive drug","volume":"1995","author":"Popik P","year":"1995","journal-title":"Pharmacol Rev"},{"key":"e_1_2_17_164_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(95)02163-9"},{"key":"e_1_2_17_165_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1024203824761"},{"key":"e_1_2_17_166_1","first-page":"110","article-title":"BP\u2010897","volume":"1","author":"Preti A","year":"2000","journal-title":"Curr Opin Investig Drugs"},{"key":"e_1_2_17_167_1","first-page":"274","article-title":"CRF antagonist","volume":"2","author":"Preti A","year":"2001","journal-title":"Curr Opin Investig Drugs"},{"key":"e_1_2_17_168_1","first-page":"272","article-title":"Tomoxetine\u2014an update","volume":"3","author":"Preti A","year":"2002","journal-title":"Curr Opin Investig Drugs"},{"key":"e_1_2_17_169_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chc.2005.08.002"},{"key":"e_1_2_17_170_1","doi-asserted-by":"publisher","DOI":"10.1159\/000079835"},{"key":"e_1_2_17_171_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.npep.2005.07.002"},{"key":"e_1_2_17_172_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n0114"},{"key":"e_1_2_17_173_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2004.06.082"},{"key":"e_1_2_17_174_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1990.03450190043026"},{"key":"e_1_2_17_175_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2005.00990.x"},{"key":"e_1_2_17_176_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2003.00350.x"},{"key":"e_1_2_17_177_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(90)90132-B"},{"key":"e_1_2_17_178_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2005.06.017"},{"key":"e_1_2_17_179_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0173(93)90013-P"},{"key":"e_1_2_17_180_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2003.08.061"},{"key":"e_1_2_17_181_1","doi-asserted-by":"publisher","DOI":"10.1038\/381"},{"key":"e_1_2_17_182_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.104.075952"},{"key":"e_1_2_17_183_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1074"},{"key":"e_1_2_17_184_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2002.tb04155.x"},{"key":"e_1_2_17_185_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.104.082503"},{"key":"e_1_2_17_186_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(91)90570-R"},{"key":"e_1_2_17_187_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1369-1600.2006.00012.x"},{"key":"e_1_2_17_188_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1998.tb09011.x"},{"key":"e_1_2_17_189_1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0031-6997(24)01492-3","article-title":"The role of corticotropin\u2010releasing factor in drug addiction","volume":"53","author":"Sarnyai Z","year":"2001","journal-title":"Pharmacol Rev"},{"key":"e_1_2_17_190_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2.1.179"},{"key":"e_1_2_17_191_1","doi-asserted-by":"publisher","DOI":"10.1080\/10550490490480982"},{"key":"e_1_2_17_192_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4603(00)00098-8"},{"key":"e_1_2_17_193_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.2.340"},{"key":"e_1_2_17_194_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200519080-00001"},{"key":"e_1_2_17_195_1","doi-asserted-by":"publisher","DOI":"10.1080\/13556210500123191"},{"key":"e_1_2_17_196_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.54.1.1"},{"key":"e_1_2_17_197_1","doi-asserted-by":"publisher","DOI":"10.1080\/09595230410001704190"},{"key":"e_1_2_17_198_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2003.00447.x"},{"key":"e_1_2_17_199_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1948034"},{"key":"e_1_2_17_200_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(96)00718-2"},{"key":"e_1_2_17_201_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(01)00205-8"},{"key":"e_1_2_17_202_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2005.00991.x"},{"key":"e_1_2_17_203_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n1207"},{"key":"e_1_2_17_204_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1999.94811132.x"},{"key":"e_1_2_17_205_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.3.324"},{"key":"e_1_2_17_206_1","doi-asserted-by":"publisher","DOI":"10.1177\/070674370204700710"},{"key":"e_1_2_17_207_1","first-page":"CD003352","article-title":"Dopamine agonists for cocaine dependence","volume":"2","author":"Soares BG","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_17_208_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200519010-00002"},{"key":"e_1_2_17_209_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(03)00157-6"},{"key":"e_1_2_17_210_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300707"},{"key":"e_1_2_17_211_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(00)00088-2"},{"key":"e_1_2_17_212_1","doi-asserted-by":"publisher","DOI":"10.1037\/1064-1297.8.4.539"},{"key":"e_1_2_17_213_1","first-page":"5","article-title":"Basic psychopharmacology of antidepressants, part 1: antidepressants have seven distinct mechanisms of action","volume":"59","author":"Stahl SM","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_17_214_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v62n1201"},{"key":"e_1_2_17_215_1","doi-asserted-by":"publisher","DOI":"10.2174\/187152706776359619"},{"key":"e_1_2_17_216_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0193-953X(05)70081-2"},{"key":"e_1_2_17_217_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(00)00456-1"},{"key":"e_1_2_17_218_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000222512.25649.08"},{"key":"e_1_2_17_219_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.yco.0000218593.08313.fd"},{"key":"e_1_2_17_220_1","doi-asserted-by":"publisher","DOI":"10.1038\/nn757"},{"key":"e_1_2_17_221_1","first-page":"215","article-title":"Cognitive concepts of craving","volume":"23","author":"Tiffany ST","year":"1999","journal-title":"Alcohol Res Health"},{"key":"e_1_2_17_222_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0076-6879(98)96033-5"},{"key":"e_1_2_17_223_1","first-page":"415","article-title":"Drug addiction. Part III. Pharmacotherapy of addiction","volume":"53","author":"Vetulani J","year":"2001","journal-title":"Pol J Pharmacol"},{"key":"e_1_2_17_224_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2396(199904)32:1<44::AID-SYN6>3.0.CO;2-9"},{"key":"e_1_2_17_225_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2005.06.010"},{"key":"e_1_2_17_226_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.8.1432"},{"key":"e_1_2_17_227_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.yco.0000165596.98552.02"},{"key":"e_1_2_17_228_1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0022-3565(24)35115-8","article-title":"Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D2 receptors","volume":"291","author":"Volkow ND","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_17_229_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199412000-00005"},{"key":"e_1_2_17_230_1","first-page":"524","article-title":"Effects of naltrexone on response to intravenous cocaine, hydromorphone and their combination in humans","volume":"279","author":"Walsh SL","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_17_231_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2005.05.006"},{"key":"e_1_2_17_232_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.188.2.109"},{"key":"e_1_2_17_233_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2005.01222.x"},{"key":"e_1_2_17_234_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2005.00992.x"},{"key":"e_1_2_17_235_1","unstructured":"WongDF CantilenaL ElkashefA YokoiF DogonS StephaneM et\u2003al.(1999)In vivo human dopamine transporter occupancy of a potential cocaine treatment agent GBR 12909.Soc Neurosci Abstr522.7 Vol 25 Part 1 p. 1298."},{"key":"e_1_2_17_236_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3458.2001.tb00195.x"},{"key":"e_1_2_17_237_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3956(00)00016-9"}],"container-title":["Addiction Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1369-1600.2007.00061.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1369-1600.2007.00061.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T07:49:59Z","timestamp":1737013799000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1369-1600.2007.00061.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,14]]},"references-count":236,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["10.1111\/j.1369-1600.2007.00061.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1369-1600.2007.00061.x","archive":["Portico"],"relation":{},"ISSN":["1355-6215","1369-1600"],"issn-type":[{"value":"1355-6215","type":"print"},{"value":"1369-1600","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,14]]},"assertion":[{"value":"2007-05-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}